The Europe Sepsis Diagnostics Market published by Market Data Forecast provides a detailed account of the Market Trends via Customized Research presented as Strategic Analyses, Company Profiles, Competitive Landscape, etc.
According to the report “Europe Sepsis Diagnostics Market By Pathogen (Bacterial And Fungal), By Product (Instruments, Blood Culture Media, Assay Kits And Reagents), By Technology (Molecular Diagnostics, Microbiology, Immunoassay And Flow Cytometry), By Method (Conventional And Automated), By Usability (Laboratory And POC) And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2016–2021)” published by Market Data Forecast, The Europe Sepsis Diagnostics Market was worth USD 96.2 million in 2016 and estimated to be growing at a CAGR of 8.6%, to reach USD 145.32 million by 2021. The increasing prevalence of the disease and its fatal affects have stimulated its growth.
Browse report details at www.marketdataforecast.com/market-…tics-market-2947/
Sepsis Diagnosis is the rise as the incidence rate and prevalence of sepsis is on the rise. Sepsis is a serious illness condition occurring when the body reacts to a foreign body infection, be it bacterial, viral, fungal or parasitic.
It is one of the most death causing disease in hospitals. Infection leads to organ dysfunction or failure and systemic inflammation.
Its symptoms are hypertension, high body temperature, shivering and high heart rate.
Factors like high incidence rates of hospital acquired infections, rising prevalence of different antibiotic resistant bacterial strains, increasing geriatric population, growing number of surgical procedures and increasing number of product approvals driving the market forward. Yet, factors like lack of standard protocols, lack of awareness and dearth or skilled staff are likely to obstruct the growth of market.
The Europe Sepsis Diagnostics market is segmented based on Pathogen, Product, Technology, Method and Usability. Based on Pathogen – Bacterial and Fungal.
Based on Product - Instruments, Blood Culture Media, Assay Kits and Reagents. Based on Technology - Molecular Diagnostics, Microbiology, Immunoassay and Flow Cytometry.
Based on Method – Conventional and Automated. Based on Usability - Laboratory and Point-of-care testing.
Based on Geographical analysis the market is separated into regions of U.K., Germany, France, Italy and Spain. U.K. is leading the market while Germany is at second place.
Growing focus of stakeholders on research projects, drug discovery and diagnosis has helped U.K. dominate the market. Germany is expected to grow the fastest owing to number of factors such as increasing number of surgical procedures, growing number of clinical studies, developing healthcare infrastructure, and rising focus of global players in this region.
Bacterial Sepsis Diagnostics have accounted for major share among the pathogen segment. Molecular Diagnostics is expected to grow the fastest among the technology segment.
Blood culture media is regarded as the standard treatment procedure and holds the major share among the products segment.
Some of the key players dominating this market include bioMérieux SA, T2 Biosystem Inc, Cepheid, Thermo Fisher Scientific Inc., Nanosphere Inc, Abbott Laboratories, Roche Diagnostics Limited, Becton, Dickinson and Company, Bruker Corporation, and Beckman Coulter, Inc.
Category: Market Research Publishers and RetailersCompany profile: Market Data Forecast is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients. A few key business areas that we handle with excellence include business process improvement, corporate financing and decision making based on market research, assisting in developing appropriate strategy and providing consultancy based on extens ...
For more information:Make an Inquiry about this report HERE!